Regencell Bioscience Holdings Limited, a herbal medicine biotech firm, has experienced an astonishing 46,000% surge in its stock value in 2025, despite generating no revenue since its inception. This Hong Kong-based company, specializing in traditional Chinese medicine for neurological conditions, saw its market capitalization soar to $30 billion.
Related Posts
Intel interim CEO ‘publicly’ shares concerns on ARM-based PCs ‘high return rates’
Qualcomm denied Intel’s claim of high return rates for Snapdragon X Elite-powered Windows PCs due to software issues. Qualcomm stated return rates are normal, with […]
‘India should lead AI revolution’: OpenAI’s Sam Altman
Union minister Ashwini Vaishnaw met OpenAI CEO Sam Altman to discuss strategies for developing an AI ecosystem in India, focusing on cost-effective models. Altman expressed […]
Sachin Tendulkar makes a return to cricket nets – Watch
Batting legend Sachin Tendulkar has returned to the cricket nets, as seen in a video shared by Mumbai Indians on social media. Tendulkar will captain […]